These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 11394456)
1. Radical transurethral resection in the management of muscle-invasive bladder cancer. Grob BM; Macchia RJ J Endourol; 2001 May; 15(4):419-23; discussion 425-6. PubMed ID: 11394456 [TBL] [Abstract][Full Text] [Related]
2. [Combined therapy for patients with invasive bladder cancer]. Startsev VIu; Karelin MI Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212 [TBL] [Abstract][Full Text] [Related]
3. Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer. Onishi T; Sekito S; Shibahara T; Yabana T Urol Oncol; 2021 Feb; 39(2):132.e1-132.e6. PubMed ID: 32792215 [TBL] [Abstract][Full Text] [Related]
4. Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate. Lavery HJ; Stensland KD; Niegisch G; Albers P; Droller MJ J Urol; 2014 Apr; 191(4):898-906. PubMed ID: 24300483 [TBL] [Abstract][Full Text] [Related]
5. Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer. Kanady KE; Shipley WU; Zietman AL; Kaufman DS; Althausen AF; Heney NM Semin Surg Oncol; 1997; 13(5):359-64. PubMed ID: 9259092 [TBL] [Abstract][Full Text] [Related]
6. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy. Herr HW Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043 [No Abstract] [Full Text] [Related]
7. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy. Witjes JA Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044 [No Abstract] [Full Text] [Related]
8. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711 [TBL] [Abstract][Full Text] [Related]
10. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice]. Huguet J Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044 [TBL] [Abstract][Full Text] [Related]
11. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation. Sternberg CN Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795 [TBL] [Abstract][Full Text] [Related]
12. Transurethral resection for muscle-invasive bladder cancer. Kondás J; Váczi L; Szecsó L; Kondér G Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277 [TBL] [Abstract][Full Text] [Related]
13. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results. Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058 [TBL] [Abstract][Full Text] [Related]
14. Can patient selection for bladder preservation be based on response to chemotherapy? Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521 [TBL] [Abstract][Full Text] [Related]
15. Organ preservation approaches with radiation therapy in muscle-invasive bladder carcinoma. Liu MC; Zietman AL; Shipley WU Ann Acad Med Singap; 1996 May; 25(3):441-7. PubMed ID: 8876914 [TBL] [Abstract][Full Text] [Related]
19. Treatment of muscle-invasive bladder cancer: progress and new challenges. Herring JC; Kamat AM Expert Rev Anticancer Ther; 2004 Dec; 4(6):1047-56. PubMed ID: 15606332 [TBL] [Abstract][Full Text] [Related]
20. Intra-arterial chemotherapy for muscle-invasive bladder cancer following transurethral resection. Liang S; Zou Q; Han B; Jing Y; Cui D; An X; Gao Y; Hu J; Xia S Urol Int; 2015; 94(4):406-11. PubMed ID: 25678415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]